Tuesday, November 17, 2026

Elpixel and AI Medical Service form a business alliance! Social implementation of endoscopic image diagnosis support AI

Elpixel and AI Medical Service, a developer of endoscopic image diagnosis support AI (artificial intelligence), announced today that they have entered into a strategic business alliance agreement to accelerate the social implementation of endoscopic image diagnosis support AI!

Background to the business alliance and the social issues we address

Elpixel provides the diagnosis support AI "EIRL" (*1) in a wide range of fields. In the endoscopy field, Elpixel provides the medical image analysis software EIRL Colon Polyp, which detects colon polyp candidates (*2) and supports doctors in colonoscopy (approval number: 30400 BZX00259000).

AI Medical Service has also started providing "endoscopic image diagnosis support software gastroAI-model G" (approval number: 30500BZX00297000), which is equipped with AI and detects lesion candidates for biopsy (*3) and other additional tests based on gross features during endoscopic examination to assist doctors in diagnosis. The company has begun offering the software.

The common issue that both companies are tackling is cancer of the digestive tract. After lung cancer, colorectal cancer and gastric cancer are the second and third leading causes of cancer deaths in Japan, respectively, with more than 90,000 deaths annually. Against this social backdrop, this business alliance was formed out of the strong desire of both companies to contribute to improving the quality of endoscopic care by using endoscopic image diagnosis support AI technology to reduce the overall number of missed cases and mortality rates due to early detection of cancers of the digestive tract.

In general, medical institutions that perform both upper and lower gastrointestinal tract examinations often perform both examinations in the same endoscopy room. Through this business alliance, AI Medical Service will begin offering "EIRL Colon Polyp," a medical image analysis software, in addition to "gastroAI-model G," an endoscopic image diagnosis support software. It will be possible to provide total support for endoscopic image diagnosis support AI for both upper and lower endoscopy, which will greatly improve the convenience for medical institutions in introducing the software.

The two companies aim to bring about a revolution in the medical field and popularize endoscopic examinations using AI technology. As a frontrunner in the field of AI image diagnosis support software, Elpixel has launched several products related to simple X-ray, CT, MRI, and endoscopic image diagnosis support in its "EIRL" image diagnosis support AI series. Leveraging this knowledge, we have collaborated with partners both within and outside the medical device industry to provide innovative products, including the launch of the "EIRL AI Partner Program. We will continue to work with our partners to solve issues in the medical field and to promote the spread of medical AI.

Comments from representatives of both companies on the business alliance

Tomohiro Tada, CEO, AI Medical Services, Inc.
One of the reasons why I founded AI Medical Service was that I challenged BRAVE, a program sponsored by Beyond Next Ventures in 2016 to promote the commercialization of research results, and won in the pre-startup category. I am deeply moved by the fact that we have entered into this business alliance with L-Pixel, a company led by Mr. Kamata, who was my mentor who first taught me what it was like to start a start-up business.

We believe that in order to develop endoscopic AI and AI medical devices into a next-generation Japanese industry that can be deployed around the world, it is essential to aim for global expansion through an all-Japan structure, and we are very pleased to have established a structure to challenge the world using this alliance as a stepping stone.

Tomihisa Kamada, Representative Director, L-Pixel Corporation
We are very pleased to announce our business alliance with AI Medical Services, a company founded by Dr. Tada, a role model innovator in the medical industry who is both a physician and an entrepreneur. This strategic collaboration is the first of its kind in the industry. We believe that this strategic collaboration will lead to new developments for our company, and we look forward to working with AI Medical Services and our various partners to accelerate the spread of medical AI and promote the social implementation of innovative products."

About AI Medical Services

AIM is a medical AI startup company with the mission of "Saving the world's patients - to achieve zero missed cancer cases with endoscopic AI". Japan is at the forefront of endoscopic medicine, and has accumulated the world's highest level of data in terms of both quality and quantity. Among them, AIM is conducting joint research and product development with more than 100 medical facilities. By bringing endoscopic AI to the medical field as quickly as possible, we aim to reduce the number of missed cancer cases and save patients around the world.

About elpixel

L-Pixel Corporation, with its strength in image analysis in the life science field, has developed highly accurate software by applying image analysis technology, especially artificial intelligence technology, in the medical, pharmaceutical, and agricultural fields. The company's business is centered on "EIRL," an AI image diagnosis support technology that assists physicians in diagnosis, and "IMACEL," an image analysis AI specialized for drug discovery.

In January 2024, we will launch the EIRL AI Partner Program, in which partner applications will be incorporated into the EIRL platform and provided to medical institutions, aiming to accelerate social implementation of advanced technologies together with our partners.

1 EIRL is a medical image diagnosis support technology that uses Elpixel's proprietary artificial intelligence (AI) algorithms. Currently introduced at more than 630 facilities (as of December 2023, including trials), EIRL analyzes all information necessary for diagnosis, including medical images such as simple X-rays, CT, MRI, and endoscope images, and provides an environment that enables doctors to make more efficient and accurate diagnoses. As an AI that accompanies physicians, we aim to realize a world in which double-checking by physicians + AI is the norm.
2 Ridge and surface type (surface ridge type)
3 "Biopsy" refers to taking a piece of tissue and examining it under a microscope when a lesion is found.

About AI Diagnostic Imaging Assistive Technology

With increasingly sophisticated modalities, medical diagnostic imaging work continues to increase, and we aim to provide an environment that enables efficient and accurate diagnosis by analyzing medical image information such as brain MRIs and chest X-rays using our unique AI-based algorithms.
EIRL product website (for healthcare professionals):https://eirl.ai/ja/

About elpixel

name of companyL-Pixel Corporation
EstablishmentMar. 2014
LocationOtemachi Building, 6-1, Otemachi 1-chome, Chiyoda-ku, Tokyo
representativeTomihisa Kamata
uniform resouce locatorhttp://lpixel.net/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
SourceLPIXEL
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。